학술논문

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Document Type
Artikel
Source
Blood advances. 7(9):1929-1943
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2473-9537